[Rituximab时代的初级外节扩散大B细胞淋巴瘤:单中心回顾分析]
Lan Yang1, Li-Xia Cao1, Hui-Juan Ren1
1Department of Hematology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, Inner Mongolia Autonomous Region, China.
Zhongguo shi yan xue ye xue za zhi
|August 27, 2024
概括
主要的外扩散性大B细胞淋巴瘤 (DLBCL) 最常见的是涉及胃肠道,预后较差. NCCN-IPI得分是这些患者生存结果的关键预测指标.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
